SNBIF (SanBio Co) Total Stockholders Equity : $9.98 Mil (As of Jul. 2024)

View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Total Stockholders Equity?

SanBio Co's Total Stockholders Equity for the quarter that ended in Jul. 2024 was $9.98 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. SanBio Co's Book Value per Share for the quarter that ended in Jul. 2024 was $0.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. SanBio Co's Debt-to-Equity for the quarter that ended in Jul. 2024 was 0.34.

SanBio Co Total Stockholders Equity Historical Data

The historical data trend for SanBio Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Total Stockholders Equity Chart

SanBio Co Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Total Stockholders Equity

Get a 7-Day Free Trial

100.03

80.45

17.72

33.95

19.09

SanBio Co Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Total Stockholders Equity	Get a 7-Day Free Trial															15.82	12.55	19.09	15.59	9.98

SanBio Co (OTCPK:SNBIF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

SanBio Co's Book Value per Share for the quarter that ended in Jul. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(9.98	-	0)	/	68.6303
	=	0.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

SanBio Co's Debt-to-Equity for the quarter that ended in Jul. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.701	+	1.67)	/	9.98
	=	0.34

SanBio Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of SanBio Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

SanBio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (OTCPK:SNBIF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

4592:Japan

Address

8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044

Website

https://www.sanbio.com

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.